// App-Quantinova.ai

: Identification and characterization of circulating tumor cells in post prostatectomy patients with localized high risk prostate cancer.

Researchers

Presenter

  • Terence W. Friedlander

Principal Investigators

  • Christopher J. Welty

  • Archana Anantharaman

  • Jeffrey Hough

  • Matthew Edwards

  • Alise Stromlund

  • Jeff Simko

  • Ryon Graf

  • Angel Rodriquez

  • Yipeng Wang

  • Peter Carroll

  • Matthew R. Cooperberg

  • Ryan Vance Dittamore

  • Pamela Paris

Medical Centers

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  • University of California, San Francisco, San Francisco, CA

  • St Marys Medical Center, San Francisco, CA

  • Epic Sciences, Inc., San Diego, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Breakpoint Cluster Region

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved